Safety of Off-Label Use of Anticancer Drugs in Oncology
Safety is recognized as a crucial issue of off-label use of anticancer drugs. The potential benefits of such prescriptions in oncology are associated with prevailing the expected clinical benefits over the risks of complications. However, in certain clinical situations with uncertain benefit/risk ra...
Saved in:
Main Authors: | E. V. Karabina, D. D. Sakaeva, O. N. Lipatov |
---|---|
Format: | Article |
Language: | English |
Published: |
Bashkir State Medical University
2024-04-01
|
Series: | Креативная хирургия и онкология |
Subjects: | |
Online Access: | https://www.surgonco.ru/jour/article/view/918 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2023-07-01) -
Safety of the Off-Label Use of Antitumor Drugs in Real Clinical Practice: Experience of Oncologists of the Russian Federation
by: E. V. Каrabina, et al.
Published: (2024-12-01) -
Off-Label Drug Use in Oncology
by: E. V. Karabina, et al.
Published: (2022-07-01) -
Exploration of Ethical Review Disputes and Regulatory Pathways of Off-label Drug Use
by: Xuelian TANG, et al.
Published: (2025-02-01) -
Off-Label Drug Use in Pediatric Practice: Unsolved Problems
by: A. R. Titova, et al.
Published: (2015-10-01)